Edition:
India

Sino Biopharmaceutical Posts Qtrly Underlying Profit Attributable RMB976.38 Mln


Tuesday, 21 May 2019 

May 21 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::QTRLY REVENUE RMB6,208.03 MILLION, AN INCREASE OF ABOUT 33.4%.QTRLY UNDERLYING PROFIT ATTRIBUTABLE RMB976.38 MILLION, UP 22.4%.BOARD HAS DECLARED PAYMENT OF A QUARTERLY DIVIDEND OF HK2 CENTS PER SHARE FOR THREE MONTHS ENDED 31 MARCH, 2019.